In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1860 News Items found
Charles Sawyers, a hematologic oncologist at Memorial Sloan Kettering Cancer Center
A Conversation with MSK’s Charles Sawyers: What’s Next for Precision Oncology

Twenty years ago, Charles Sawyers played a pivotal role in the development of Gleevec, a game-changing cancer drug that has gone on to save millions of lives and open doors for research and innovation. In this episode, Dr. Diane Reidy-Lagunes talks with Dr. Sawyers about what’s next in the field of cancer pharmaceuticals. Is another silver bullet on the horizon?
Chief Operating Officer Kathryn Martin
Chief Operating Officer Kathryn Martin Receives Distinguished Leadership Honor

Kathryn was honored with The Leon J. Warshaw Leadership in Healthcare Award.
Mike Philbin
Finding
How Telemedicine Reshaped Genetic Counseling during the COVID-19 Pandemic

A recent study from MSK investigators found that most patients who received genetic counseling by telemedicine during the early months of the pandemic reported being highly satisfied with the care they received.
Mary Ann Cornell stands behind the wheel of a boat.
Finding
Drug Combination Improves Outcomes for Common Type of Lymphoma

An international phase 3 trial has found that polatuzumab vedotin improves outcomes for patients with newly diagnosed diffuse large B cell lymphoma.
Updates from SABCS 2021: Personalizing Diet and Exercise Plans for Breast Cancer, Zapping Metastatic Cells, Making Targeted Drugs Work Better

MSK physicians and researchers discussed the latest trends in breast cancer research at the annual meeting held in San Antonio.
Memorial Sloan Kettering adolescent young adult (AYA) patient Eliza Wierzbinska
Coping with Cancer at the Holidays: 7 Tips from Someone Who Has Been There

Find ways to cope with cancer during the holiday season.
Francesca Gany
MSK Joins the American Cancer Society Cancer Action Network for Policy Forum on Health Equity

MSK’s Francesca Gany emphasized the need to overcome the digital and linguistic divides between the healthcare system and communities.
Kalina Belcheva, Teddy Yewdell, Jayanta Chaudhuri, and Ryan Smolkin standing together in a lab
In the Lab
SKI Research Reveals New Insights into Immune Response to Viral Infections — Including COVID-19

Research from Sloan Kettering Institute immunologists suggests that the body may mount an immune response to respiratory viruses that lasts longer than previously thought. The discovery could impact the timing of COVID-19 vaccinations.
Craig B. Thompson
Craig B. Thompson Named to AMNY Metro and PoliticsNY’s Power Players in Health Care List

The list honors health care leaders who envision a better future for all New Yorkers.
SKI immunologist Andrea Schietinger
Discovery of a Stem-like T Cell in Type 1 Diabetes Holds Potential for Improving Cancer Immunotherapy, Sloan Kettering Institute Scientists Say

As an autoimmune disease, Type 1 diabetes raises important questions about immune cell activity that have broad implications for immunotherapy.